I have not posted for a long time, mainly because I’ve been in excellent health.
In summary, I was diagnosed with GCA in May 2017, had terrible reactions to Prednisolone (severe psychosis being the worst- apparently 1 in 20 people suffer this) such that my husband had to call out the Crisis team.
After several relapses, and a PET-CT scan revealing I additionally had severe large vessel arteritis , my Consultant managed to get me on self-injected Ro-Actemra. This worked miraculously for me- no side effects, no illnesses (apart from a slight cold last year). I have been off Prednisolone, and all other medications for more than 3 years, after having been on it for 3 years (and made very ill by it, not to mention stacking up a very high accumulated dose).
The one year allocation allowed by NICE was extended because of Covid, and (entirely off my own bat) I decided to inject every 2 weeks, then 3 weeks, instead of weekly, to eke out my supply, with no reduction in its effectiveness.
I was thus able to be on Ro-Actemra (Tocilizumab) for nearly 4 years, but my last injection was in May this year, and a blood test last week shows I am having a major relapse 10 weeks after my last injection.
Now it seems my only option is to wait for a stroke or aneurysm to finish me off; my consultant, lovely though she is, says she cannot prescribe more because of NICE’s edict that for GCA, only one year is allowed.
I have tried to obtain it privately, and pay for it, but even this is not allowed! Why not?!
I know I am one of the lucky ones to have been given Tocilizumab in the first place, BUT it is totally reprehensible, and discriminatory (this condition after all, mainly affects elderly ladies).
When NICE can approve expensive biological drugs for Alziemers ( which affects far more people), not to mention drugs to treat obesity, and £1.89 million pounds per patient to slow down (not stop) certain very rare degenerative conditions, it cannot be justified.
My ( and our) only option seems to be a judicial review of NICE’s decision on this. I cannot be the only one in this situation, in the UK. It seems that the one year rule does not apply in all countries; and some countries (Australia for eg.) have done a deal with Roche so that patients can buy the drug themselves, but of course, the request has to be made through a Consultant. I mentioned this to my consultant, and she hadn’t heard of it, so it won’t happen.
If anyone has any ideas, I would love to hear them. Otherwise, I might not be around much longer!